The research study is being done to see if ziltivekimab can be used to treat people who were admitted to hospital because of a heart attack. Ziltivekimab might reduce development of heart disease, thereby preventing new heart attacks or strokes. Participants will either get ziltivekimab (active medicine) or placebo (a dummy medicine which has no effect on the body). Which treatment participants get is decided by chance. The chance of getting ziltivekimab or placebo is the same. The participant will need to inject the study medicine into a flat skin surface in there stomach, thigh, or upper arm once every month. Ziltivekimab is not yet approved in any country or region in the world. It is a new medicine that doctors cannot prescribe. The study will last for about 2 years.
Cardiovascular Risk, Acute Myocardial Infarction (AMI)
The research study is being done to see if ziltivekimab can be used to treat people who were admitted to hospital because of a heart attack. Ziltivekimab might reduce development of heart disease, thereby preventing new heart attacks or strokes. Participants will either get ziltivekimab (active medicine) or placebo (a dummy medicine which has no effect on the body). Which treatment participants get is decided by chance. The chance of getting ziltivekimab or placebo is the same. The participant will need to inject the study medicine into a flat skin surface in there stomach, thigh, or upper arm once every month. Ziltivekimab is not yet approved in any country or region in the world. It is a new medicine that doctors cannot prescribe. The study will last for about 2 years.
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
-
Advanced Cardiovascular, LLC, Alexander City, Alabama, United States, 35010
Birmingham VA Medical Center, Birmingham, Alabama, United States, 35233
Grandview Medical Center, Birmingham, Alabama, United States, 35243
Eastern Shore Rsrch Inst, LLC, Fairhope, Alabama, United States, 36532
Heart Center Rsrch_Hunstville, Huntsville, Alabama, United States, 35801
Mobile Heart USA Health Cardiology Clinic, Mobile, Alabama, United States, 36606
Mercy Gilbert Medical Center, Gilbert, Arizona, United States, 85297
Mayo Clinic Arizona, Phoenix, Arizona, United States, 85054
Honor Health, Scottsdale, Arizona, United States, 85258
Arkansas Cardiology Clinic, Little Rock, Arkansas, United States, 72205
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
18 Years to
ALL
No
Novo Nordisk A/S,
Clinical Transparency dept. 2834, STUDY_DIRECTOR, Novo Nordisk A/S
2026-09-03